AbbVie presents 60 abstracts and presentations from a robust portfolio spanning across alopecia areata, atopic dermatitis, hidradenitis suppurativa, non-segmental vitiligo, psoriasis and psoriatic ...

Locals looking for holistic alternatives and natural lifestyle solutions gathered at the Lloyd Ex for the latest Health and Wellness Show.

Parkinson’s disease is a brain disorder that gradually affects movement and many other body functions. It develops as nerve ...

The FDA has approved tavapadon (AbbVie), a once-daily oral selective dopamine D1/D5 receptor partial agonist, for adults with ...

On Monday, Sept. 28, the U.S. Food and Drug Administration approved a new treatment that targets dopamine pathways critical ...

JUVMO™ is the first and only selective D1/D5 receptor agonist approved for adults with Parkinson's disease1 Taken once daily with or without levodopa therapy, JUVMO offers patients ...

The FDA has approved Juvmo, the first and only dopamine agonist for adults with Parkinson’s disease designed to selectively ...

STAPLES — Lakewood Health System was awarded a $10,000 Community Grant from the Parkinson’s Foundation, making it one of only ...

Some people live with essential tremor for years and organically find ways to adapt. Others may begin avoiding activities.

Not a question of "which is superior," but differences in qualifications, roles, target conditions, insurance systems, and ...

Basic knowledge for "treating the whole body," not just motor symptomsWhen you hear Parkinson's disease, you might first think of "hand tremors" or "difficulty walking." However, the important point ...

The ​US Food and ‌Drug Administration has approved AbbVie's drug ​for Parkinson's disease ​in adults, the health ⁠regulator's ...